MNOV
MNOV
NASDAQ · Biotechnology

Medicinova Inc

$1.40
-0.03 (-2.10%)
As of May 16, 2:15 AM ET ·
Financial Highlights (FY 2026)
Revenue
405.6K
Net Income
-11,948,632
Gross Margin
7.6%
Profit Margin
-2,928.8%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 7.6% 36.9% 36.9% 36.9%
Operating Margin -3,242.4% -6.1% -6.2% -5.2%
Profit Margin -2,928.8% -4.9% -5.0% -5.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 405.6K 11.04M 11.56M 10.16M
Gross Profit 30.7K 4.07M 4.26M 3.74M
Operating Income -13,151,920 -678,619 -711,893 -528,734
Net Income -11,948,632 -536,425 -578,623 -557,404
Gross Margin 7.6% 36.9% 36.9% 36.9%
Operating Margin -3,242.4% -6.1% -6.2% -5.2%
Profit Margin -2,928.8% -4.9% -5.0% -5.5%
Rev Growth +9.7% -0.5% +16.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 32.67M 29.36M 29.97M
Total Equity 34.04M 33.10M 34.09M
D/E Ratio 0.96 0.89 0.88
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -13,224,131 -810,707 -735,622 -650,086
Free Cash Flow -370,627 -351,629 -405,371